The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading ->
The $9.4 billion package agreed to by the US Senate and House Appropriations Committees, is more than double the $3.7 billion requested by the Trump Administration, and signals bipartisan support for maintaining significant global health aid – although the package still must be approved by both Senate and House, and could also be vetoed by […] Continue reading ->
While the US Environmental Protection Agency (EPA) will still consider the health benefits of emissions regulations, it will no longer publish estimates of the economic costs of deaths, illness and disability from unsafe air pollution levels. The US EPA, whose path-finding work on air pollution’s health impacts helped set standards internationally, will no longer put […] Continue reading ->
Governments should “significantly strengthen” taxes on alcoholic and sugary drinks as these products are getting cheaper, fueling obesity, diabetes, heart disease, cancers and injuries. This is according to the World Health Organization (WHO), which issued two reports on taxing sugary drinks and alcohol on Tuesday, including how countries are implementing these. “In most countries, these […] Continue reading ->
Over December, the United States signed bilateral health co-operation agreements with 14 African countries, setting out the parameters for aid in exchange for speedy information about new disease outbreaks – and, in some instances, clinched alongside trade deals profitable to US companies. The fourteen countries, in order of when the agreements were signed, are: Kenya, […] Continue reading ->